Patient Cost and Assistance Programs

OPTIONS TO HELP ELIGIBLE PATIENTS WITH ACCESS TO XELJANZ AFTER A PRESCRIBING DECISION HAS BEEN MADE
Commercial Insurance
Co-Pay Savings Program*—Eligible patients may be able to reduce out-of-pocket costs, with a maximum benefit of $15,000 per calendar year
Additional offers for eligible, commercially insured patients by request
Interim Care Rx—Up to 6 months of free XELJANZ shipped to eligible patients during a delay in prior authorization or appeal
Government-Funded Insurance
Locating alternative funding sources
For those patients who need help with their medication cost-sharing requirements, Pfizer will refer patients who appear to be eligible to Medicare Extra Help
Pfizer Patient Assistance Program
Free XELJANZ shipped directly to eligible, underinsured patients
No Insurance Coverage
Locating alternative funding sources
For those patients who need help with their medication cost-sharing requirements, Pfizer will refer patients who appear to be eligible to Medicaid
Pfizer Patient Assistance Program
Eligible patients may receive XELJANZ at no charge
*Administered by TrialCard. Availability subject to patient eligibility requirements and/or applicable limits, terms, and conditions. See Terms & Conditions.
The free product for this program is for certain commercially insured patients only. Not available to residents in the states of MA, IA, MN, MO, OH, or RI. See Terms & Conditions.
The Pfizer Patient Assistance Program is a joint program of Pfizer Inc. and the Pfizer Patient Assistance FoundationTM. Free medicines from Pfizer are provided through the Pfizer Patient Assistance FoundationTM. The Pfizer Patient Assistance Foundation is a separate legal entity from Pfizer Inc. with distinct legal restrictions.
JAK=Janus kinase.